- Conditions
- Erythematotelangiectatic Rosacea, Papulopustular Rosacea
- Interventions
- Apremilast
- Drug
- Lead sponsor
- Julian M. Mackay-Wiggan
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2014
- U.S. locations
- 1
- States / cities
- New York, New York
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–13
of 13
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Papulopustular Rosacea, Erythematotelangiectatic Rosacea
- Interventions
- Reference: Metronidazole Gel 1%, Test: Metronidazole Gel 1%, Placebo Gel
- Drug
- Lead sponsor
- bioRASI, LLC
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 963 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015
- U.S. locations
- 27
- States / cities
- Los Angeles, California • San Diego, California • Boca Raton, Florida + 23 more
- Conditions
- Rosacea, Erythematotelangiectatic
- Interventions
- Trametinib
- Drug
- Lead sponsor
- Albany Research Institute, Inc.
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- Albany, New York
- Conditions
- Rosacea
- Interventions
- vehicle gel, Atralin gel
- Drug
- Lead sponsor
- Lisa E. Maier
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 68 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2013
- U.S. locations
- 1
- States / cities
- Ann Arbor, Michigan
- Conditions
- Rosacea
- Interventions
- B244, Vehicle
- Biological
- Lead sponsor
- AOBiome LLC
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 140 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 9
- States / cities
- Clearwater, Florida • Miami, Florida • Miramar, Florida + 4 more
- Conditions
- Rosacea, Papulopustular, Rosacea, Erythematotelangiectatic
- Interventions
- KTP Laser Therapy, Radiofrequency microneedling
- Device
- Lead sponsor
- University of Miami
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- Miami Beach, Florida
- Conditions
- Erythematotelangiectatic Rosacea
- Interventions
- CD07805/47, CD07805/47 placebo
- Drug
- Lead sponsor
- Galderma R&D
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 122 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009
- U.S. locations
- 5
- States / cities
- Hot Springs, Arkansas • Fort Washington, Pennsylvania • Austin, Texas + 2 more
- Conditions
- Erythematotelangiectatic Rosacea, Rosacea
- Interventions
- Ulthera System Treatment
- Device
- Lead sponsor
- Ulthera, Inc
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 88 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2016
- U.S. locations
- 4
- States / cities
- Omaha, Nebraska • Wilmington, North Carolina • Hummelstown, Pennsylvania + 1 more
- Conditions
- Rosacea, Rosacea, Erythematotelangiectatic, Flushing
- Interventions
- Transaricular vagus nerve stimulation (taVNS)
- Device
- Lead sponsor
- Brigham and Women's Hospital
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Erythematotelangiectatic Rosacea
- Interventions
- The Vbeam® Prima System, Oxymetazoline HCL 1% Cream
- Device · Drug
- Lead sponsor
- Candela Corporation
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 34 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2021
- U.S. locations
- 2
- States / cities
- Charlotte, North Carolina • Houston, Texas
- Conditions
- Erythematotelangiectatic Rosacea
- Interventions
- calcium dobesilate, pulsed dye laser
- Drug · Procedure
- Lead sponsor
- Ellen Marmur
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Rosacea, Erythematotelangiectatic
- Interventions
- Metronidazole cream, Cetaphil moisturizer, CeraVe moisturizer, Eucerin Healing Lotion moisturizer, Aveeno Calm and Restore Oat Gel moisturizer
- Drug · Other
- Lead sponsor
- Duke University
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 21 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2025
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
- Conditions
- Erythematotelangiectatic Rosacea, Papulopustular Rosacea
- Interventions
- 532nm KTP Laser vs 595nm Pulse Dye Laser
- Device
- Lead sponsor
- Cutera Inc.
- Industry
- Eligibility
- 20 Years to 80 Years · Female only
- Enrollment
- 22 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2015
- U.S. locations
- 1
- States / cities
- Miami, Florida